Module 1: Surgical Site Infections (SSI): Beyond Antibiotics On Call to OR

Please note, this workshop must be complete by July 26, 2023.

ACOS Quality Improvement and Patient Safety eLearning Series

Module 1: Surgical Site Infections (SSI): Beyond Antibiotics On Call to OR

Presented by Geeta Lal, MD, MSc FRCS(C), FACS

Session description

This session will provide an overview of the burden of SSI as a postoperative complication and review how SSI is defined by various bodies such as the CDC and ACS-NSQIP. It will also discuss the value of registries such as ACS-NSQIP in evaluating SSI rates to determine the need for quality improvement in this arena. The importance of reviewing the entire peri-operative period to identify issues that increase SSI risk will be emphasized. In addition, the utility of implementing bundled improvements, along with continuous monitoring and feedback, to maintain changes will also be reviewed.

Learning Objectives

At the end of the session, the participate should be able to:

1. Review the definition(s) of SSI
2. Discuss the use of American College of Surgeons - National Surgical Quality Improvement Program (ACS-NSQIP) to evaluate SSI data
3. Review guidelines and best practices for SSI reduction

This session will include time for Q&A and interactivity with the instructor.

Eligible webinar participants will earn 1.5 AOA Category 1-A CME credits for this eLearning Series.

Unable to attend the live webinars? ACOS understands that scheduled webinar dates and times may not work with everyone's calendar. As a result, all sessions will be recorded and available on-demand. If you register now, you will have access to both the live version and the recording as soon as it's available. This on-demand access comes with unlimited viewing! You will receive a notification in your ACOS eLearning account - typically within 24 hours - once the recording is available.

Geeta Lal, MD, MSc, FACS

Staff Surgeon, University of Iowa Hospitals

Geeta Lal, MD, MSc FRCS(C), FACS.

Dr. Lal is an Associate Professor of Surgery at the University of Iowa, where she serves as Co-Leader of the Endocrine Multi-disciplinary Oncology Group (at the Holden Comprehensive Cancer Center) and Associate Chief Quality Officer and Director of In-patient Quality and Safety.

Her clinical interest is in endocrine surgery, with a focus in thyroid and parathyroid disease including pediatric thyroid cancer. She was an NIH-funded investigator with an interest in the role of ECM1 in thyroid, breast and other malignancies. She has also authored or co-authored numerous peer-reviewed publications and book chapters. She is a member of: